Hepatitis C Intervention Symposia Series – United States

Join us at one of our upcoming symposiums and learn how to implement different evidence-based interventions for hepatitis C (HCV) in your setting, such as point-of-care testing, dried blood spot testing, peer support, HCV care navigation and medical record auditing.

Showcase good practice
Be inspired by examples of different interventions for hepatitis C across a variety of settings. 


Highlight latest research 
Find out about the latest research about interventions to enhance the HCV care cascade. 


Build on your own model of care
Experts will support you to implement new interventions to your existing model of care for HCV. 


Build new connections 
We will help you make connections with experts and like-minded colleagues from across the country. 

Who is it for?

This event is for anyone in the United States interested in implementing or scaling up interventions for HCV in their service setting, including doctors, nurses, frontline workers, peer workers, pharmacists and pharmacy staff, policy makers, and any other staff working in drug and alcohol or primary care settings with some existing knowledge of HCV. 

After attending this event, you will be able to:

  • Identify areas for enhancing or scaling up in your own HCV service delivery 
  • Understand how a variety of interventions work 
  • Identify suitable interventions to enhance your own HCV service delivery
  • Describe how the intervention could be implemented in your service setting 
  • Analyze possible barriers to implementing interventions and how to overcome them

Upcoming events

Past events

United States Steering Committee


The program is developed and delivered in collaboration with many partners. With thanks to our co-chairs, the National Alliance of State & Territorial AIDS Directors (NASTAD) and the Coalition for Global Hepatitis Elimination (CGHE) and well as our National Expert Steering Committee: 

  • Jordan Akerley
    Strategic Director, End Hep C SF
  • Jasmine West
    Manager, Hepatitis, NASTAD
  • Isabel Lechuga,
    Associate Director, Hepatitis, NASTAD
  • John Ward
    Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health
  • Lindsey Hiebert
    Associate Director, Coalition for Global Hepatitis Elimination, The Task Force for Global Health
  • Natasha Martin
    Professor, Division of Infectious Diseases and Global Public Health, University of California San Diego
  • Alain Litwin
    Executive Director, Addiction Medicine Center, Prisma Health | Professor of Medicine, University of South Carolina School of Medicine | Professor, Clemson University School of Health Research | Vice Chair of Academics and Research, Prisma Health
  • Matthew Akiyama
    Associate Professor of Medicine Divisions of General Internal Medicine & Infectious Diseases, Albert Einstein College of Medicine
  • Anthony Martinez
    Associate Professor of Medicine, Jacobs School of Medicine, University at Buffalo | Medical Director, Hepatology, Erie County Medical Center
  • Judith Feinberg
    Vice Chair, Research & Professor, Infectious Diseases, West Virginia University
  • Oluwaseun Falade-Nwulia,
    Associate Professor, Division of Infectious Diseases, John Hopkins
  • Adrienne Simmons
    Pharmacist, Director of Programs, National Viral Hepatitis Roundtable




With thanks to our series sponsors, AbbVie, Gilead Sciences and Roche. Sponsorship is governed by our Sponsorship Policy and the sponsors have no control over content, tone, emphasis, allocation of funds or selection of recipients. INHSU does not endorse or promote any sponsor’s product or service.